Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 10/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | CTSG | P08311 | 1/20 | 0.44 |
| ▸ | CMA1 | P23946 | 1/20 | 0.44 |
| ▸ | CTRC | Q99895 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8142750 | 0.94 | MGLL (0.57) | MGLLF2ELANECTSGCMA1 | |
| SCHEMBL4839640 | 0.92 | MGLL (0.61) | MGLLFAAHHSP90AA1PKMMAPK1 | |
| SCHEMBL9065005 | 0.90 | MGLL (0.53) | MGLLF2ELANECTSGCMA1 | |
| SCHEMBL10704906 | 0.90 | MEN1 (0.56) | MGLLELANEMEN1KMT2ANPC1 | |
| SCHEMBL8443563 | 0.90 | MGLL (0.53) | MGLLF2ELANECTSGCMA1 | |
| SCHEMBL774452 | 0.89 | MGLL (0.50) | MGLLELANEFAAHMEN1KMT2A | |
| SCHEMBL13632610 | 0.88 | ALDH1A1 (0.42) | MGLLF2ELANECTSGCMA1 | |
| SCHEMBL9198677 | 0.88 | MGLL (0.38) | MGLLF2ELANECTSGCMA1 | |
| SCHEMBL4391609 | 0.88 | MGLL (0.49) | MGLLF2ELANECTSGCMA1 | |
| SCHEMBL3828130 | 0.88 | MGLL (0.55) | MGLLF2ELANECTSGCMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0449292-B1 | Multilayer printed circuit board and production thereof | HITACHI LTD (JP) | 1997-08-20 | — | — | EP | claimed |
| JP-4202514-A | — | — | None | — | — | JP | disclosed |
| JP-11140183-A | — | — | None | — | — | JP | disclosed |
| WO-2025031588-A1 | CURABLE ORGANOSILOXANE-MODIFIED REACTION RESINS | WACKER CHEMIE AG (DE) | 2025-02-13 | — | — | WO | disclosed |
| EP-4347702-A1 | CROSS-LINKABLE ORGANOSILOXANE-MODIFIED REACTION RESINS | Wacker Chemie AG (DE) | 2024-04-10 | — | — | EP | disclosed |
| US-20230365730-A1 | HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF | KANEKA CORPORATION (JP) | 2023-11-16 | — | — | US | disclosed |
| US-20230365730-A1 | HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF | KANEKA CORPORATION (JP) | 2023-11-16 | — | — | US | disclosed |
| CN-115877658-A | Curable photosensitive resin composition, cured product, resist pattern and method for producing same, semiconductor element, and electronic device | 荒川化学工业株式会社 | 2023-03-31 | — | — | CN | disclosed |
| WO-2022253413-A1 | CROSS-LINKABLE ORGANOSILOXANE-MODIFIED REACTION RESINS | WACKER CHEMIE AG (DE) | 2022-12-08 | — | — | WO | disclosed |
| US-11421049-B2 | Photopolymerization synergist | Piedmont Chemical Industries, LLC (US) | 2022-08-23 | — | — | US | disclosed |
| US-5480947-A | N-METHYLOL DIGUANAMINES | MITSUI TOATSU CHEMICALS, INC. (JP) | 1996-01-02 | — | — | US | disclosed |
| US-5426155-A | Adjuvants which prevent loss of crosslinking in vulcanized rubbers | AKZO NOBEL N.V. (NL) | 1995-06-20 | — | — | US | disclosed |
| EP-0364785-B1 | Thermosetting resin composition, printed circuit board using the resin composition and process for producing printed circuit board | HITACHI LTD (JP) | 1995-03-01 | — | — | EP | disclosed |
| EP-0634406-A1 | DIGUANAMINE, AND PRODUCTION, DERIVATIVE AND USE THEREOF | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1995-01-18 | — | — | EP | disclosed |
| US-5352762-A | Fluorine-containing biscyanamide thermosetting resin, heat resistance, adhesion | HITACHI, LTD. (JP) | 1994-10-04 | — | — | US | disclosed |
| JP-H04202514-A | CURABLE COMPOSITION | SEKISUI FINE CHEM KK | 1992-07-23 | — | — | JP | disclosed |
| EP-0449292-A2 | Multilayer printed circuit board and production thereof | HITACHI, LTD. (JP) | 1991-10-02 | — | — | EP | disclosed |
| US-5045381-A | Containing (iso)cyanate compound and poly(p-hydroxystyrene) derivative | HITACHI, LTD. (JP) | 1991-09-03 | — | — | US | disclosed |
| EP-0378457-A2 | Aromatic allyl amine thermosetting resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-07-18 | — | — | EP | disclosed |
| EP-0364785-A1 | Thermosetting resin composition, printed circuit board using the resin composition and process for producing printed circuit board | HITACHI, LTD. (JP) | 1990-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365730-A1 | HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF | KDM5C, DHX15, KDM5A | MGLL 4346/4885F2 688/4885ELANE 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.